Simplify Logo
Nudge

Nudge

Non-invasive neuromodulation headset via ultrasound

Member of Research Staff - Preclinical

Full-Time
No salary listed
Mid
Bachelor's, Master's, PhD
San Francisco, CA, USA
In Person

About the job

Requirements
  • Hands-on experience working in a preclinical or animal research laboratory is required; neuroscience experience is preferred.
  • Experience handling rodents, including mice and/or rats, and familiarity with basic in vivo techniques such as dosing, anesthesia, perfusion, and tissue harvest are required.
  • Familiarity with sterile cell culture technique is required.
  • The candidate must be comfortable fabricating simple fixtures, adapting equipment, and solving practical problems in the laboratory.
  • High integrity and strong professional judgment are required.
Responsibilities
  • Execute rodent experiments involving mice and rats in compliance with standardized protocols.
  • Perform and support in vivo procedures, including animal stereotaxic surgery, neural imaging, electrophysiology, behavior, and ultrasound delivery.
  • Perform rodent perfusions, brain extraction, and tissue collection for downstream histological and molecular analysis.
  • Conduct in vitro cell culture and brain slice experiments.
  • Design, build, and improve experimental setups, tools, and laboratory workflows.
Desired Qualifications
  • Experience with stereotactic viral injections or cranial window implantations.
  • A Bachelor's, Master's, or PhD in neuroscience, biology, or a related field.
  • Neuroscience experience.

About the company

Generate a concise company summary answering: 1) what the company does, 2) how its product works, 3) how it differs from competitors, 4) its goal, based on the provided description.

Company Size

11-50

Company Stage

Series A

Total Funding

$100M

Headquarters

San Francisco, California

Founded

2025

Get referred to Nudge

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2025 funding gave Nudge capital for trials and device iteration.
  • Current studies are enrolling for essential tremor, chronic pain, tinnitus, and healthy volunteers.
  • Patient applications are planned soon, expanding from research toward clinical revenue.

What critics are saying

  • Nudge still runs feasibility studies, not treatment studies, for chronic pain and SUD.
  • Regulators can halt ultrasound brain claims before commercialization in 2026.
  • If safety or efficacy fails, Nudge becomes an expensive research platform, not a product.

What makes Nudge unique

  • Focused ultrasound lets Nudge stimulate and image brain tissue without surgery.
  • July 2025 Series A from Thrive Capital and Greenoaks validates the platform.
  • Nudge Zero reached human-ready testing within months, showing rare execution speed.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

2%

2 year growth

18%
Equity Bulls
Aug 12th, 2025
FSN E-Commerce acquires 40% Nudge stake

FSN E-Commerce Ventures Ltd has approved the acquisition of the remaining 40% stake in Nudge Wellness Pvt Ltd from Onesto Labs Pvt Ltd, as per the terms of a shareholders' agreement from April 2022. Onesto will no longer hold any stake in Nudge post-transaction. FSN's stock traded at ₹203.60 on BSE, with a high of ₹204.25 and a low of ₹200.25, and a net turnover of ₹9.53 million.

Dealroom.co
Jul 26th, 2025
Nudge company information, funding & investors

Nudge, non-invasive neuromodulation headset enhancing brain function through precise stimulation and imaging. Here you'll find information about their funding, investors and team.

Nudge
Jul 25th, 2025
Announcing Nudge's $100M Series A Fundraise

Nudge - Whole-brain interfaces for everyday life